Advancing IBD Treatment: Leveraging Innovative Models and Therapies for Enhanced Drug Development
Speaker: Dr. Luo (Jack) Jia,
Sr. Scientist/Study Director, Team Lead for Disease Modeling at Biocytogen
Inflammatory Bowel Disease (IBD) is a chronic autoimmune disorder in which the body’s immune system triggers inflammation in the gastrointestinal tract. Affecting nearly one in 100 people in the United States, IBD presents significant challenges for treatment development due to its complex pathology and the limitations of conventional research models.
In this webinar, Dr. Luo (Jack) Jia, the Senior Scientist/Study Director and Team Lead for Disease Modeling at Biocytogen, will explore the current challenges in IBD treatment development, explain how targeted humanized mouse models are advancing IBD research, and outline future directions for drug discovery and translatability in this field.
Key Topics Include:
- Current Therapeutic Landscape and Challenges for IBD
- Conventional and Targeted Humanized Mouse Models in IBD Research
- Future Directions for IBD Drug Discovery and Translatability